LCAT and neoplasm: The KEGG enrichment analysis results indicate that LCAT is most likely to promote ACC tumor progression through the IL-17 signaling pathway (Figure 13A); LCAT is most likely to promote COAD tumor progression through complement and coagulation cascades (Figure 13B).